Radiogenomics and Imaging Phenotypes in Glioblastoma: Novel Observations and Correlation with Molecular Characteristics
暂无分享,去创建一个
[1] R. Gilbertson,et al. Stem cells of ependymoma , 2006, British Journal of Cancer.
[2] Albert Lai,et al. Apparent diffusion coefficient histogram analysis stratifies progression-free and overall survival in patients with recurrent GBM treated with bevacizumab: a multi-center study , 2012, Journal of Neuro-Oncology.
[3] A. Osborn. Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging , 2008 .
[4] R A Betensky,et al. Tumor location and growth pattern correlate with genetic signature in oligodendroglial neoplasms. , 2001, Cancer research.
[5] James M Provenzale,et al. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. , 2002, Radiology.
[6] Carlo Pierpaoli,et al. High Temporal Resolution Diffusion MRI of Global Cerebral Ischemia and Reperfusion , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[7] T Tolxdorff,et al. In vivo NMR T2 relaxation of experimental brain tumors in the cat: a multiparameter tissue characterization. , 1992, Magnetic resonance imaging.
[8] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[9] R. Turner,et al. Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[10] Ferenc A. Jolesz,et al. Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme , 2011, PloS one.
[11] R R Edelman,et al. Cerebral blood flow: assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. , 1990, Radiology.
[12] S. Schoenberg,et al. Brain Tumor Enhancement in MR Imaging at 3 Tesla: Comparison of SNR and CNR Gain Using TSE and GRE Techniques , 2007, Investigative radiology.
[13] T. Cloughesy,et al. Probabilistic Radiographic Atlas of Glioblastoma Phenotypes , 2013, American Journal of Neuroradiology.
[14] J. Smirniotopoulos,et al. Glioblastoma multiforme: radiologic-pathologic correlation. , 1996, Radiographics : a review publication of the Radiological Society of North America, Inc.
[15] G. Stewart,et al. Researches on the Circulation Time and on the Influences which affect it , 1897, The Journal of physiology.
[16] D. Ayer,et al. Coordination of glucose and glutamine utilization by an expanded Myc network , 2010, Transcription.
[17] Takashi Aoi,et al. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts , 2008, Nature Biotechnology.
[18] M. Kuo,et al. Radiogenomic analysis to identify imaging phenotypes associated with drug response gene expression programs in hepatocellular carcinoma. , 2007, Journal of vascular and interventional radiology : JVIR.
[19] A. Giaccia,et al. The hypoxic tumor microenvironment and gene expression. , 2004, Seminars in radiation oncology.
[20] Chi V Dang,et al. MYC on the Path to Cancer , 2012, Cell.
[21] R. Bourgon,et al. Correlation of molecular subtypes with survival in AVAglio (bevacizumab [Bv] and radiotherapy [RT] and temozolomide [T] for newly diagnosed glioblastoma [GB]). , 2014 .
[22] Glyn Johnson,et al. Dynamic, contrast‐enhanced perfusion MRI in mouse gliomas: Correlation with histopathology , 2003, Magnetic resonance in medicine.
[23] L. Bozzao,et al. Radiological assessment of necrosis in glioblastoma: variability and prognostic value , 1998, Neuroradiology.
[24] D. Nelson,et al. Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials. , 1993, International journal of radiation oncology, biology, physics.
[25] Matthew S. Brown,et al. Recurrent glioblastoma multiforme: ADC histogram analysis predicts response to bevacizumab treatment. , 2009, Radiology.
[26] S. Atlas,et al. Magnetic resonance image–guided proteomics of human glioblastoma multiforme , 2003, Journal of magnetic resonance imaging : JMRI.
[27] William D. Dunn,et al. MR imaging predictors of molecular profile and survival: multi-institutional study of the TCGA glioblastoma data set. , 2013, Radiology.
[28] P. Kelly,et al. Glioma vascularity correlates with reduced patient survival and increased malignancy. , 2009, Surgical neurology.
[29] J. Folkman. Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.
[30] C. Kruchko,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005-2009. , 2012, Neuro-oncology.
[31] K. Aldape,et al. Identification of noninvasive imaging surrogates for brain tumor gene-expression modules , 2008, Proceedings of the National Academy of Sciences.
[32] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[33] A. Rutman,et al. Radiogenomics: creating a link between molecular diagnostics and diagnostic imaging. , 2009, European journal of radiology.
[34] Mark S. Cohen,et al. Contrast agents and cerebral hemodynamics , 1991, Magnetic resonance in medicine.
[35] Paul S Mischel,et al. MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.
[36] J. M. Taylor,et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. , 2000, Journal of the National Cancer Institute.
[37] Pascal O. Zinn,et al. A Novel Volume-Age-KPS (VAK) Glioblastoma Classification Identifies a Prognostic Cognate microRNA-Gene Signature , 2012, PloS one.
[38] B R Rosen,et al. NMR imaging of changes in vascular morphology due to tumor angiogenesis , 1998, Magnetic resonance in medicine.
[39] J. Barnholtz-Sloan,et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.
[40] Naoki Kagawa,et al. Fractional anisotropy and tumor cell density of the tumor core show positive correlation in diffusion tensor magnetic resonance imaging of malignant brain tumors , 2008, NeuroImage.
[41] M. Scott,et al. The developmental biology of brain tumors. , 2001, Annual review of neuroscience.
[42] R. Mirimanoff,et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. , 2005, The New England journal of medicine.
[43] Mitchel S Berger,et al. Regional variation in histopathologic features of tumor specimens from treatment-naive glioblastoma correlates with anatomic and physiologic MR Imaging. , 2012, Neuro-oncology.
[44] P. Lai,et al. Diffusion-weighted MRI features of brain abscess and cystic or necrotic brain tumors: comparison with conventional MRI. , 2002, Clinical imaging.
[45] Isabel Wanke,et al. Neuroimaging of infections , 2005 .
[46] Z L Gokaslan,et al. A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.
[47] C. Ball,et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. , 2002, Molecular biology of the cell.
[48] Michael H Lev,et al. Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas [corrected]. , 2004, AJNR. American journal of neuroradiology.
[49] B. Rosen,et al. Perfusion imaging with NMR contrast agents , 1990, Magnetic resonance in medicine.
[50] W. Curry,et al. LIMITATIONS OF DIFFUSION‐WEIGHTED IMAGING IN THE DIAGNOSIS OF POSTOPERATIVE INFECTIONS , 2008, Neurosurgery.
[51] B A Kall,et al. Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms. , 1987, Journal of neurosurgery.
[52] T. Cascino,et al. Response criteria for phase II studies of supratentorial malignant glioma. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[53] B. Rosen,et al. Functional mapping of the human visual cortex by magnetic resonance imaging. , 1991, Science.
[54] A. Satterfield,et al. TREATMENT , 1924, California and western medicine.
[55] A. Miller,et al. Reporting results of cancer treatment , 1981, Cancer.
[56] B. Rosen,et al. Dynamic imaging with lanthanide chelates in normal brain: Contrast due to magnetic susceptibility effects , 1988, Magnetic resonance in medicine.
[57] P. LaViolette,et al. Validation of functional diffusion maps (fDMs) as a biomarker for human glioma cellularity , 2010, Journal of magnetic resonance imaging : JMRI.
[58] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[59] P. Basser,et al. Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. , 1996, Journal of magnetic resonance. Series B.
[60] Mitchel S Berger,et al. Neural stem cells and the origin of gliomas. , 2005, The New England journal of medicine.
[61] Zhaoshi Jiang,et al. Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[62] Olav Haraldseth,et al. Measurement of cell density and necrotic fraction in human melanoma xenografts by diffusion weighted magnetic resonance imaging , 2000, Magnetic resonance in medicine.
[63] Scott VandenBerg,et al. Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype. , 2007, Neuro-oncology.
[64] Max Wintermark,et al. Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project , 2014, BMC Medical Genomics.
[65] Raymond Sawaya,et al. Prognostic significance of preoperative MRI scans in glioblastoma multiforme , 2004, Journal of Neuro-Oncology.
[66] David Gutman,et al. Genomic mapping and survival prediction in glioblastoma: molecular subclassification strengthened by hemodynamic imaging biomarkers. , 2013, Radiology.
[67] H. B. Verheul,et al. Comparison of diffusion‐weighted MRI with changes in cell volume in a rat model of brain injury , 1994, NMR in biomedicine.
[68] J. Uhm. Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group , 2010 .
[69] D. Norman,et al. Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors. , 1977, Journal of neurosurgery.
[70] C. Dang. MYC, metabolism, cell growth, and tumorigenesis. , 2013, Cold Spring Harbor perspectives in medicine.
[71] Toshinori Hirai,et al. Usefulness of diffusion‐weighted MRI with echo‐planar technique in the evaluation of cellularity in gliomas , 1999, Journal of magnetic resonance imaging : JMRI.
[72] Sonja Loges,et al. Silencing or fueling metastasis with VEGF inhibitors: antiangiogenesis revisited. , 2009, Cancer cell.
[73] D. Zagzag,et al. Angiogenesis in Gliomas: Biology and Molecular Pathophysiology , 2005, Brain pathology.
[74] R. Mirimanoff,et al. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial. , 2009, The Lancet. Oncology.
[75] T Hackländer,et al. Measurement of cerebral blood volume via the relaxing effect of low-dose gadopentetate dimeglumine during bolus transit. , 1996, AJNR. American journal of neuroradiology.
[76] K. Zierler,et al. On the theory of the indicator-dilution method for measurement of blood flow and volume. , 1954, Journal of applied physiology.
[77] R. Damadian. Tumor Detection by Nuclear Magnetic Resonance , 1971, Science.
[78] P J Basser,et al. New Histological and Physiological Stains Derived from Diffusion‐Tensor MR Images , 1997, Annals of the New York Academy of Sciences.
[79] T E Walsh,et al. Reporting results. , 1969, Archives of otolaryngology.
[80] Daniel L. Rubin,et al. The caBIG™ Annotation and Image Markup Project , 2009, Journal of Digital Imaging.
[81] Sylvia Drabycz,et al. An analysis of image texture, tumor location, and MGMT promoter methylation in glioblastoma using magnetic resonance imaging , 2010, NeuroImage.
[82] F Di Salle,et al. Diffusion MRI in patients with transient ischemic attacks. , 1999, Stroke.
[83] Nancy J Fischbein,et al. Differentiation of low-grade oligodendrogliomas from low-grade astrocytomas by using quantitative blood-volume measurements derived from dynamic susceptibility contrast-enhanced MR imaging. , 2005, AJNR. American journal of neuroradiology.
[84] S. Gabriel,et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. , 2010, Cancer cell.
[85] T. Hirai,et al. Diffusion-weighted imaging of metastatic brain tumors: comparison with histologic type and tumor cellularity. , 2006, AJNR. American journal of neuroradiology.
[86] Robert J. Harris,et al. Anatomic localization of O6-methylguanine DNA methyltransferase (MGMT) promoter methylated and unmethylated tumors: A radiographic study in 358 de novo human glioblastomas , 2012, NeuroImage.
[87] T. Cloughesy,et al. Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma , 2012, American Journal of Neuroradiology.
[88] Howard Colman,et al. MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma. , 2010, Neuro-oncology.
[89] A. Berns,et al. Induction of medulloblastomas in p53-null mutant mice by somatic inactivation of Rb in the external granular layer cells of the cerebellum. , 2000, Genes & development.
[90] Soonmee Cha,et al. Quantitative apparent diffusion coefficients and T2 relaxation times in characterizing contrast enhancing brain tumors and regions of peritumoral edema , 2005, Journal of magnetic resonance imaging : JMRI.
[91] Franck Couillaud,et al. MMP‐7 (matrilysin) expression in human brain tumors , 2007, Molecular carcinogenesis.
[92] Scar,et al. Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. , 2000, The New England journal of medicine.
[93] M S Brown,et al. Apparent Diffusion Coefficient Histogram Analysis Stratifies Progression-Free Survival in Newly Diagnosed Bevacizumab-Treated Glioblastoma , 2011, American Journal of Neuroradiology.
[94] Benjamin M Ellingson,et al. Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images. , 2013, Neuro-oncology.
[95] Mark R. Gilbert,et al. Erratum: MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma (Neuro-Oncology (2010) 12:2 (116-121)) , 2010 .
[96] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[97] S. Nelson,et al. Differential Gene Expression in Glioblastoma Defined by ADC Histogram Analysis: Relationship to Extracellular Matrix Molecules and Survival , 2012, American Journal of Neuroradiology.
[98] Paul S Mischel,et al. Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis. , 2008, Radiology.
[99] M T Nieminen,et al. Potential of diffusion imaging in brain tumors: a review , 2006, Acta radiologica.
[100] A P Pathak,et al. MR‐derived cerebral blood volume maps: Issues regarding histological validation and assessment of tumor angiogenesis , 2001, Magnetic resonance in medicine.
[101] A. Pathak,et al. Antiangiogenic effects of dexamethasone in 9L gliosarcoma assessed by MRI cerebral blood volume maps. , 2003, Neuro-oncology.
[102] Joel H. Saltz,et al. The Proneural Molecular Signature Is Enriched in Oligodendrogliomas and Predicts Improved Survival among Diffuse Gliomas , 2010, PloS one.
[103] D. Rubin,et al. The Annotation and Image Mark-up project. , 2009, Radiology.